Drugs – Real World Outcomes targets research involving the use of real-world data to evaluate health outcomes and inform healthcare decision-making, with a particular focus on healthcare-related ‘big data’. Drugs-Real World Outcomes has a broad scope, encompassing studies investigating drug utilisation, patterns of prescribing, pharmacovigilance, treatment guideline adherence, benefit-risk assessments, comparative effectiveness and economic analyses. Available here. (Source: Dene Peters, Anton Rensburg, Adis).
You are here: / / New Journal Targets Real-World Data, Health Outcomes, Healthcare Decision-Making & Big Data